Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


James Long

James Long, Fishers, IN US

Patent application numberDescriptionPublished
20090005728THERAPY DELIVERY SYSTEM HAVING AN OPEN ARCHITECTURE AND A METHOD THEREOF - A therapy delivery system having an open architecture and method of providing thereof are disclosed. The present invention provides a therapy dosage module having a control algorithm that can be replaced with a predefined or independently defined control algorithm. The tools necessary to create and test such control algorithms in the therapy dosage module in a simulated environment before implementing it in a live therapy system are also disclosed.01-01-2009
20100324932METHODS AND SYSTEMS FOR ADVISING PEOPLE WITH DIABETES - A method and system for advising a person with diabetes to perform a task based on the recommended therapy are disclosed. A library of one or more tasks is established, wherein each task in the library is related to a therapy recommended to the person with diabetes. Personal and real-time data related to the person's diabetic condition are recorded such that advice provided to the person to perform a task from the library is based on the recorded personal and real-time data. In this manner, the embodiments of the present invention simplify the ability of a person with diabetes to follow a recommended therapy.12-23-2010

James Long, Salt Lake City, UT US

Patent application numberDescriptionPublished
20100241223WEARABLE VAD CONTROLLER WITH RESERVE BATTERY - There is disclosed apparatus and methods for providing a reserve power source for a ventricular assist device. In an embodiment, the apparatus includes a primary power source for powering the device, and a controller housing having a reserve battery for powering the device when the primary power source provides inadequate power, and the controller housing configured for use externally of the patient with a percutaneous cable to the device. In another embodiment, a method includes powering the device with a primary power source, monitoring power provided to the device, powering the device when the power is monitored as inadequate to the device with a reserve power source disposed within a controller housing, the device disposed subcutaneously within a patient, the controller housing disposed externally of the patient, and the device and the controller housing connected by a percutaneous cable. Other embodiments are also disclosed.09-23-2010

James Long, Lantana, TX US

Patent application numberDescriptionPublished
20100102057REUSABLE CONTAINER - A reusable container for storing or transporting a product to be refrigerated or frozen such as a food product is provided, comprising an inner wall, an outer wall, and a wall space provided between the inner wall and the outer wall. The wall space is substantially separated from the environment outside of the reusable container and a slurry is provided in the wall space. In some embodiments, the container can be generally rectangular or generally cylindrical. A method of shipping a product to be refrigerated or frozen in a reusable container and a method of producing a reusable container are also provided.04-29-2010

James Long, Sunnyvale, CA US

Patent application numberDescriptionPublished
20100019985Header with integral antenna for implantable medical devices - Antenna assemblies for an implantable medical device are disclosed. The implantable medical device comprises a hermetically sealed housing, typically formed of titanium materials, and electronics, including a transceiver, disposed therein. An antenna is disposed in an air, gas or plastic dielectric filled compartment within a header, which is attached to the housing. The header is premolded so as to create the compartment. The antenna is then placed within the compartment, which is then sealed.01-28-2010

James Long, Wirral GB

Patent application numberDescriptionPublished
20090175953Nanodispersions - The invention provides process for making contra-soluble nano-dispersions of at most sparingly-soluble materials in a soluble carrier material comprising the steps of: (i) providing a single phase mixture of: a) a solvent or a mixture of miscible solvents, b) at least one carrier material soluble in solvent (a), said carrier material being also contra-soluble to payload material (c) and solid at ambient temperature, c) at least one a payload material which is soluble in solvent (a), and, (ii) drying the mixture to remove solvent (a) and thereby obtain the carrier material (b) in solid form with payload (c) dispersed therein as nanoparticles.07-09-2009
20090239749Biocidal compositions - The invention provides a solvent-free biocidal composition of improved efficacy comprising at least one water insoluble biocide (preferably a herbicide) and a water-soluble carrier material, wherein the water-insoluble biocide is dispersed through the carrier material in nano-disperse form having a peak diameter of the nano-disperse form below 1000 nm. The invention also provides a process which comprises spray drying a solution of the biocide and a solution of a water-soluble carrier to obtain a solvent free dispersion of the biocide in the carrier, which, when dissolved in water, produces a nano-disperse biocide. The invention also provides an aqueous dispersion of a water insoluble biocide and a water-soluble carrier obtained by the dispersion of the composition of the solvent free composition in water.09-24-2009
20090304806Pharmaceutical Compositions - A process for the production of a composition comprising a water-insoluble sartan which comprises the steps of: a) providing a mixture comprising: i) a water-insoluble sartan, ii) a water soluble carrier, iii) a solvent for each of the sartan and the carrier, and b) spray-drying the mixture to remove the or each solvent and obtain a substantially solvent-free nano-dispersion of the sartan in the carrier.12-10-2009
20100015229Pharmaceutical compositions - A process for the production of a composition comprising a water-insoluble statin which comprises the steps of: a) providing a mixture comprising: i) a water-insoluble statin ii) a water soluble carrier, iii) a solvent for each of the statin and the carrier, and b) spray-drying the mixture to remove the or each solvent and obtain a substantially solvent-free nano-dispersion of the statin in the carrier.01-21-2010
20100015233anti-parasitic compositions - The present invention relates to nanodisperse antiparasitics and provides a composition comprising at least one water insoluble anti-parasitic drug and a water-soluble carrier material, wherein the water-insoluble anti-parasitic drug (preferably an Artemisinin-type drug or a quinine type drug) is dispersed through the carrier material in nano-disperse form having a peak diameter of the nano-disperse form below 1000 nm. The invention further provides an aqueous dispersion of a water insoluble anti-parasitic drug and a water-soluble carrier material, wherein the anti-parasitic drug is in nano-disperse form having a peak diameter of the nano-disperse form below 1000 nm, the invention further subsists in a process for preparing an anti-parasitic composition comprising a water insoluble anti-parasitic agent and a water-soluble carrier, which comprises the steps of either: a) providing an emulsion comprising a solution of the anti-parasitic agent in a water-immiscible solvent for the same, and an aqueous solution of the carrier, or providing a mixture comprising at least one non-aqueous solvent optional water a water-soluble carrier material soluble in the mixture and a water-insoluble anti-parasitic agent soluble in the mixture, and, b) drying the emulsion (preferably by spray drying) to remove water and the water-immiscible solvent to obtain a substantially solvent-free nano-dispersion of the anti-parasitic agent in the carrier.01-21-2010

James Long, Wirral Cheshire GB

Patent application numberDescriptionPublished
20100008995Processes for preparing pharmaceutical compositions - A process for the production of a composition comprising a water-insoluble triptan which comprises the steps of: a) providing a mixture comprising: i) a water-insoluble triptan, ii) a water soluble carrier, and iii) a solvent for each of the triptan and the carrier, and b) spray-drying the mixture to remove the or each solvent and obtain a substantially solvent-free nano-dispersion of the triptan in the carrier.01-14-2010

James Long, Oxton GB

Patent application numberDescriptionPublished
20090325995Preparation of pharmaceutical formulations - A process for the production of a composition comprising a water-insoluble opioid which comprises the steps of: a) providing a mixture comprising: i) a water-insoluble opioid, ii) a water soluble carrier, and iii) a solvent for each of the opioid and the carrier, and b) spray-drying the mixture to remove the or each solvent and obtain a substantially solvent-free nano-dispersion of the opioid in the carrier12-31-2009

James Long, Hong Kong CN

Patent application numberDescriptionPublished
20080313305TWO-TIER ARCHITECTURE FOR REMOTE ACCESS SERVICE - Remote access service is provided between two or more computers on a network to facilitate a variety of activities, including desktop sharing, web-meetings, and web-conferences. A first computer sends its connection information to a server. The server stores the connection information for the first computer. A second computer may make a request to the server to remotely access the first computer. The server sends to the second computer the connection information it has stored for the first computer. The second computer uses the connection information for the first computer to send to the first computer connection information for the second computer via direct network connection. From this point on, the first computer and the second computer exchange data for remote access via a direct network connection, independently of the server.12-18-2008